Entrada Therapeutics (TRDA) Q2 2026 Earnings

7MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Next
-1.15
-1.05
-0.95
-0.85

Details

Expected EPS
-1.036712
Actual EPS
N/A
Surprise EPS
1.04
Surprise Percent
+100%

Description

Entrada Therapeutics (TRDA) will report earnings of for Q2 2026 on May 07, 2026.

0 Comments

Share your thoughts